200 related articles for article (PubMed ID: 35331853)
1. Puerarin attenuates LPS-induced inflammatory injury in gastric epithelial cells by repressing NLRP3 inflammasome-mediated apoptosis.
Peng ZT; Liu H
Toxicol In Vitro; 2022 Jun; 81():105350. PubMed ID: 35331853
[TBL] [Abstract][Full Text] [Related]
2. The Overexpression of Sirtuin1 (SIRT1) Alleviated Lipopolysaccharide (LPS)-Induced Acute Kidney Injury (AKI) via Inhibiting the Activation of Nucleotide-Binding Oligomerization Domain-Like Receptors (NLR) Family Pyrin Domain Containing 3 (NLRP3) Inflammasome.
Gao Q; Zhu H
Med Sci Monit; 2019 Apr; 25():2718-2726. PubMed ID: 30980521
[TBL] [Abstract][Full Text] [Related]
3. Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway.
Arioz BI; Tastan B; Tarakcioglu E; Tufekci KU; Olcum M; Ersoy N; Bagriyanik A; Genc K; Genc S
Front Immunol; 2019; 10():1511. PubMed ID: 31327964
[TBL] [Abstract][Full Text] [Related]
4. Oxymatrine attenuates oxidized low‑density lipoprotein‑induced HUVEC injury by inhibiting NLRP3 inflammasome‑mediated pyroptosis via the activation of the SIRT1/Nrf2 signaling pathway.
Jin X; Fu W; Zhou J; Shuai N; Yang Y; Wang B
Int J Mol Med; 2021 Oct; 48(4):. PubMed ID: 34368883
[TBL] [Abstract][Full Text] [Related]
5. Puerarin protects against myocardial ischemia/reperfusion injury by inhibiting inflammation and the NLRP3 inflammasome: The role of the SIRT1/NF-κB pathway.
Wang ZK; Chen RR; Li JH; Chen JY; Li W; Niu XL; Wang FF; Wang J; Yang JX
Int Immunopharmacol; 2020 Dec; 89(Pt B):107086. PubMed ID: 33068868
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes.
Qiu Z; He Y; Ming H; Lei S; Leng Y; Xia ZY
J Diabetes Res; 2019; 2019():8151836. PubMed ID: 30911553
[TBL] [Abstract][Full Text] [Related]
7. Using Network Pharmacology for Systematic Understanding of Geniposide in Ameliorating Inflammatory Responses in Colitis Through Suppression of NLRP3 Inflammasome in Macrophage by AMPK/Sirt1 Dependent Signaling.
Pu Z; Liu Y; Li C; Xu M; Xie H; Zhao J
Am J Chin Med; 2020; 48(7):1693-1713. PubMed ID: 33202149
[TBL] [Abstract][Full Text] [Related]
8. Klotho inhibits the activation of NLRP3 inflammasome to alleviate lipopolysaccharide-induced inflammatory injury in A549 cells and restore mitochondrial function through SIRT1/Nrf2 signaling pathway.
Zeng Y; Xu G; Feng C; Cai D; Wu S; Liu Y; Chen Y; Ma W
Chin J Physiol; 2023; 66(5):335-344. PubMed ID: 37929344
[TBL] [Abstract][Full Text] [Related]
9. Puerarin mitigated LPS-ATP or HG-primed endothelial cells damage and diabetes-associated cardiovascular disease via ROS-NLRP3 signalling.
Wei H; Sun M; Wang R; Zeng H; Zhao B; Jin S
J Cell Mol Med; 2024 May; 28(10):e18239. PubMed ID: 38774996
[TBL] [Abstract][Full Text] [Related]
10. The protective effect of doxofylline against lipopolysaccharides (LPS)-induced activation of NLRP3 inflammasome is mediated by SIRT1 in human pulmonary bronchial epithelial cells.
Jiao P; Li W; Shen L; Li Y; Yu L; Liu Z
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):687-694. PubMed ID: 32098511
[TBL] [Abstract][Full Text] [Related]
11. Puerarin alleviates hyperosmotic stress-induced oxidative stress, inflammation, apoptosis and barrier damage of human corneal epithelial cells by targeting SIRT1/NLRP3 signaling.
Dong Y; Ding YY; Gao WP
Toxicol In Vitro; 2024 Feb; 94():105722. PubMed ID: 37865300
[TBL] [Abstract][Full Text] [Related]
12. [Effects of resveratrol-mediated inhibition of NOD-like receptor protein 3 inflammasomevia activating silent information regulator 1 on the injury of intestinal mucosal barrier function after sepsis].
Gulifeire T; Yang C; Li X; Wang Y; Yu X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 May; 33(5):535-540. PubMed ID: 34112288
[TBL] [Abstract][Full Text] [Related]
13. [Activation of NOD-like receptor protein 3 inflammasome mediates inflammatory response and apoptosis in septic intestinal injury model].
Gulifeire T; Yang C; Li X; Wang Y; Yu X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jul; 33(7):855-860. PubMed ID: 34412757
[TBL] [Abstract][Full Text] [Related]
14. Leptin is upregulated in epididymitis and promotes apoptosis and IL-1β production in epididymal epithelial cells by activating the NLRP3 inflammasome.
Lin N; Song X; Chen B; Ye H; Wang Y; Cheng X; Wang H
Int Immunopharmacol; 2020 Nov; 88():106901. PubMed ID: 33182054
[TBL] [Abstract][Full Text] [Related]
15. SIRT1 Alleviates LPS-Induced IL-1β Production by Suppressing NLRP3 Inflammasome Activation and ROS Production in Trophoblasts.
Park S; Shin J; Bae J; Han D; Park SR; Shin J; Lee SK; Park HW
Cells; 2020 Mar; 9(3):. PubMed ID: 32188057
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol Inhibits NLRP3 Inflammasome-Induced Pyroptosis and miR-155 Expression in Microglia Through Sirt1/AMPK Pathway.
Tufekci KU; Eltutan BI; Isci KB; Genc S
Neurotox Res; 2021 Dec; 39(6):1812-1829. PubMed ID: 34739715
[TBL] [Abstract][Full Text] [Related]
17. Thymol Alleviates LPS-Induced Liver Inflammation and Apoptosis by Inhibiting NLRP3 Inflammasome Activation and the AMPK-mTOR-Autophagy Pathway.
Dou X; Yan D; Liu S; Gao L; Shan A
Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889766
[TBL] [Abstract][Full Text] [Related]
18. To Analyze the Mechanism of SalB Regulating SIRT1 to Inhibit NLRP3 and Its Ameliorative Effect on Tubulogastric Junction Tumor Lesions Complicated with Myocardial Injury.
Wang GP; Guo Z
Biomed Res Int; 2022; 2022():6560693. PubMed ID: 36277894
[TBL] [Abstract][Full Text] [Related]
19. UFL1 modulates NLRP3 inflammasome activation and protects against pyroptosis in LPS-stimulated bovine mammary epithelial cells.
Li C; Wang X; Kuang M; Li L; Wang Y; Yang F; Wang G
Mol Immunol; 2019 Aug; 112():1-9. PubMed ID: 31078114
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of liraglutide in an experimental mouse model of multiple sclerosis: role of AMPK/SIRT1 signaling and NLRP3 inflammasome.
Ammar RA; Mohamed AF; Kamal MM; Safar MM; Abdelkader NF
Inflammopharmacology; 2022 Jun; 30(3):919-934. PubMed ID: 35364735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
